| Rosario P Bonafede, MD | |
|
5050 Ne Hoyt St, Ste 155, Portland, OR 97213-2956 | |
| (503) 215-6819 | |
| (503) 215-6492 |
| Full Name | Rosario P Bonafede |
|---|---|
| Gender | Male |
| Speciality | Rheumatology |
| Experience | 50 Years |
| Location | 5050 Ne Hoyt St, Portland, Oregon |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1730125667 | NPI | - | NPPES |
| P00745121 | Other | RR MEDICARE | |
| 054416 | Medicaid | OR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RR0500X | Internal Medicine - Rheumatology | MD16090 (Oregon) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Providence Portland Medical Center | Portland, OR | Hospital |
| Providence Willamette Falls Medical Center | Oregon city, OR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Providence Health And Services Oregon | 0648183608 | 1328 |
News Archive
Using what is thought to be the world's smallest pipette, two researchers at the U.S. Department of Energy's Brookhaven National Laboratory have shown that tiny droplets of liquid metal freeze much differently than their larger counterparts.
Twin County Regional Healthcare (TCRH) has entered into a new agreement that will secure the hospital's position as a trusted provider of quality healthcare services for years to come. The TCRH Board of Directors and Duke LifePoint Healthcare today announced they have signed a definitive agreement to jointly own and operate Twin County Regional Healthcare and its affiliated assets.
Controlling blood pressure with any of the commonly prescribed antihypertensive medications can prevent dementia in older African-Americans with hypertension according to a new study from Regenstrief Institute researchers.
The network "Grandmothers 4 Grandmothers" in Regina, Canada - the local effort of the Stephen Lewis Foundation's network of grandmother organizations called Grandmothers to Grandmothers - has "emerged as a force to be reckoned with" among the 70,000 Canadians supporting the foundation, the Regina Leader-Post reports.
Enzon Pharmaceuticals, Inc. today announced that the first patient has been treated in the Phase 1 study of PEG-SN38 for pediatric cancer patients. PEG-SN38 or EZN-2208 is Enzon's PEGylated form of SN38, the active metabolite of the cancer drug Camptosar® (irinotecan HCl injection). The study is designed to find the recommended dose of PEG-SN38 in pediatric patients. The PEG-SN38 compound is currently being evaluated in Phase 2 studies for metastatic colorectal and breast cancer.
› Verified 2 days ago
| Entity Name | Providence Health & Services Oregon |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023488343 PECOS PAC ID: 0648183608 Enrollment ID: O20031106000652 |
News Archive
Using what is thought to be the world's smallest pipette, two researchers at the U.S. Department of Energy's Brookhaven National Laboratory have shown that tiny droplets of liquid metal freeze much differently than their larger counterparts.
Twin County Regional Healthcare (TCRH) has entered into a new agreement that will secure the hospital's position as a trusted provider of quality healthcare services for years to come. The TCRH Board of Directors and Duke LifePoint Healthcare today announced they have signed a definitive agreement to jointly own and operate Twin County Regional Healthcare and its affiliated assets.
Controlling blood pressure with any of the commonly prescribed antihypertensive medications can prevent dementia in older African-Americans with hypertension according to a new study from Regenstrief Institute researchers.
The network "Grandmothers 4 Grandmothers" in Regina, Canada - the local effort of the Stephen Lewis Foundation's network of grandmother organizations called Grandmothers to Grandmothers - has "emerged as a force to be reckoned with" among the 70,000 Canadians supporting the foundation, the Regina Leader-Post reports.
Enzon Pharmaceuticals, Inc. today announced that the first patient has been treated in the Phase 1 study of PEG-SN38 for pediatric cancer patients. PEG-SN38 or EZN-2208 is Enzon's PEGylated form of SN38, the active metabolite of the cancer drug Camptosar® (irinotecan HCl injection). The study is designed to find the recommended dose of PEG-SN38 in pediatric patients. The PEG-SN38 compound is currently being evaluated in Phase 2 studies for metastatic colorectal and breast cancer.
› Verified 2 days ago
| Entity Name | Providence Health & Services Oregon |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003991845 PECOS PAC ID: 5395656284 Enrollment ID: O20031113000626 |
News Archive
Using what is thought to be the world's smallest pipette, two researchers at the U.S. Department of Energy's Brookhaven National Laboratory have shown that tiny droplets of liquid metal freeze much differently than their larger counterparts.
Twin County Regional Healthcare (TCRH) has entered into a new agreement that will secure the hospital's position as a trusted provider of quality healthcare services for years to come. The TCRH Board of Directors and Duke LifePoint Healthcare today announced they have signed a definitive agreement to jointly own and operate Twin County Regional Healthcare and its affiliated assets.
Controlling blood pressure with any of the commonly prescribed antihypertensive medications can prevent dementia in older African-Americans with hypertension according to a new study from Regenstrief Institute researchers.
The network "Grandmothers 4 Grandmothers" in Regina, Canada - the local effort of the Stephen Lewis Foundation's network of grandmother organizations called Grandmothers to Grandmothers - has "emerged as a force to be reckoned with" among the 70,000 Canadians supporting the foundation, the Regina Leader-Post reports.
Enzon Pharmaceuticals, Inc. today announced that the first patient has been treated in the Phase 1 study of PEG-SN38 for pediatric cancer patients. PEG-SN38 or EZN-2208 is Enzon's PEGylated form of SN38, the active metabolite of the cancer drug Camptosar® (irinotecan HCl injection). The study is designed to find the recommended dose of PEG-SN38 in pediatric patients. The PEG-SN38 compound is currently being evaluated in Phase 2 studies for metastatic colorectal and breast cancer.
› Verified 2 days ago
| Entity Name | Providence Health & Services - Oregon |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912282369 PECOS PAC ID: 5294901922 Enrollment ID: O20120319000430 |
News Archive
Using what is thought to be the world's smallest pipette, two researchers at the U.S. Department of Energy's Brookhaven National Laboratory have shown that tiny droplets of liquid metal freeze much differently than their larger counterparts.
Twin County Regional Healthcare (TCRH) has entered into a new agreement that will secure the hospital's position as a trusted provider of quality healthcare services for years to come. The TCRH Board of Directors and Duke LifePoint Healthcare today announced they have signed a definitive agreement to jointly own and operate Twin County Regional Healthcare and its affiliated assets.
Controlling blood pressure with any of the commonly prescribed antihypertensive medications can prevent dementia in older African-Americans with hypertension according to a new study from Regenstrief Institute researchers.
The network "Grandmothers 4 Grandmothers" in Regina, Canada - the local effort of the Stephen Lewis Foundation's network of grandmother organizations called Grandmothers to Grandmothers - has "emerged as a force to be reckoned with" among the 70,000 Canadians supporting the foundation, the Regina Leader-Post reports.
Enzon Pharmaceuticals, Inc. today announced that the first patient has been treated in the Phase 1 study of PEG-SN38 for pediatric cancer patients. PEG-SN38 or EZN-2208 is Enzon's PEGylated form of SN38, the active metabolite of the cancer drug Camptosar® (irinotecan HCl injection). The study is designed to find the recommended dose of PEG-SN38 in pediatric patients. The PEG-SN38 compound is currently being evaluated in Phase 2 studies for metastatic colorectal and breast cancer.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rosario P Bonafede, MD Po Box 3158, Portland, OR 97208-3158 Ph: (503) 215-6494 | Rosario P Bonafede, MD 5050 Ne Hoyt St, Ste 155, Portland, OR 97213-2956 Ph: (503) 215-6819 |
News Archive
Using what is thought to be the world's smallest pipette, two researchers at the U.S. Department of Energy's Brookhaven National Laboratory have shown that tiny droplets of liquid metal freeze much differently than their larger counterparts.
Twin County Regional Healthcare (TCRH) has entered into a new agreement that will secure the hospital's position as a trusted provider of quality healthcare services for years to come. The TCRH Board of Directors and Duke LifePoint Healthcare today announced they have signed a definitive agreement to jointly own and operate Twin County Regional Healthcare and its affiliated assets.
Controlling blood pressure with any of the commonly prescribed antihypertensive medications can prevent dementia in older African-Americans with hypertension according to a new study from Regenstrief Institute researchers.
The network "Grandmothers 4 Grandmothers" in Regina, Canada - the local effort of the Stephen Lewis Foundation's network of grandmother organizations called Grandmothers to Grandmothers - has "emerged as a force to be reckoned with" among the 70,000 Canadians supporting the foundation, the Regina Leader-Post reports.
Enzon Pharmaceuticals, Inc. today announced that the first patient has been treated in the Phase 1 study of PEG-SN38 for pediatric cancer patients. PEG-SN38 or EZN-2208 is Enzon's PEGylated form of SN38, the active metabolite of the cancer drug Camptosar® (irinotecan HCl injection). The study is designed to find the recommended dose of PEG-SN38 in pediatric patients. The PEG-SN38 compound is currently being evaluated in Phase 2 studies for metastatic colorectal and breast cancer.
› Verified 2 days ago
Salona Shrestha, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 4805 Ne Glisan St, Portland, OR 97213 Phone: 503-215-2392 | |
Dr. Emmanuel Trungtoan Tavan, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 2800 N Vancouver Ave, Suite 230, Portland, OR 97227 Phone: 503-413-2901 | |
Ginevra Lois Liptan, M.D. Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 6400 Sw Canyon Ct, Ste 100, Portland, OR 97221 Phone: 503-477-9616 Fax: 503-477-9808 | |
Donald Richard Sullivan, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 3181 Sw Sam Jackson Park Rd, Uhn67, Portland, OR 97239 Phone: 503-494-6949 | |
Dr. Victor Nguyen Pham, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 9205 Sw Barnes Rd, Portland, OR 97225 Phone: 503-216-2906 | |
Richa Uppal, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 800 Sw 13th Ave, Portland, OR 97205 Phone: 503-221-0161 Fax: 503-274-1697 | |
Reem Hasan, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 3181 Sw Sam Jackson Park Rd, Ppv 350, Portland, OR 97239 Phone: 503-494-8562 |